Why Is Breast Cancer-Focused BriaCell Therapeutics Stock Trading Over 100% On Wednesday

On Wednesday, BriaCell Therapeutics BCTX stock traded higher with a session volume of 113.08 million, compared to the average volume of 366.19 thousand, according to data from Benzinga Pro.BriaCell Therapeutics announced overall survival data from its Phase 2 clinical study of Bria-IMT in combination with an immune checkpoint inhibitor (CPI) in late-stage metastatic breast cancer.The company reported a median overall survival of 15.6 months from its most recent patients (treated since 2022) vs. 6.7-9.3 mont ...